BIOMAT Database Logo BIOMAT Database Logo

Synthesis and antiviral activity of 3'-heterocyclic substituted 3'-deoxythymidines. 1990

P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium.

Various 3'-deoxythymidine analogues with an heterocyclic five-membered ring in the 3'-erythro position have been synthesized. The pyrrol-1-yl (3) and the 1,2,4-triazol-4-yl (5) compounds were synthesized from 1-(3-amino-2,3-dideoxy-beta-D-erythro-pentofuranosyl)thymine. The pyrazol-1-yl (16a), imidazol-1-yl (16b), and 1,2,4-triazol-1-yl (16c) derivatives were obtained by epoxide opening of the corresponding 1-(2,3-anhydro-beta-D-lyxofuranosyl)thymines followed by 2'-deoxygenation. Only the 3'-pyrrol-1-yl derivative showed marginal antiviral activity against human immunodeficiency virus.

UI MeSH Term Description Entries
D002472 Cell Transformation, Viral An inheritable change in cells manifested by changes in cell division and growth and alterations in cell surface properties. It is induced by infection with a transforming virus. Transformation, Viral Cell,Viral Cell Transformation,Cell Transformations, Viral,Transformations, Viral Cell,Viral Cell Transformations
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002621 Chemistry A basic science concerned with the composition, structure, and properties of matter; and the reactions that occur between substances and the associated energy exchange.
D003588 Cytopathogenic Effect, Viral Visible morphologic changes in cells infected with viruses. It includes shutdown of cellular RNA and protein synthesis, cell fusion, release of lysosomal enzymes, changes in cell membrane permeability, diffuse changes in intracellular structures, presence of viral inclusion bodies, and chromosomal aberrations. It excludes malignant transformation, which is CELL TRANSFORMATION, VIRAL. Viral cytopathogenic effects provide a valuable method for identifying and classifying the infecting viruses. Cytopathic Effect, Viral,Viral Cytopathogenic Effect,Cytopathic Effects, Viral,Cytopathogenic Effects, Viral,Effect, Viral Cytopathic,Effect, Viral Cytopathogenic,Effects, Viral Cytopathic,Effects, Viral Cytopathogenic,Viral Cytopathic Effect,Viral Cytopathic Effects,Viral Cytopathogenic Effects
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013936 Thymidine A nucleoside in which THYMINE is linked to DEOXYRIBOSE. 2'-Deoxythymidine,Deoxythymidine,2' Deoxythymidine

Related Publications

P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Synthesis, antitumor activity, and antiviral activity of 3-substituted 3-deazacytidines and 3-substituted 3-deazauridines.
July 1990, Journal of medicinal chemistry,
P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Synthesis of N-substituted 3'-amino-3'-deoxythymidines and their biological evaluation against HIV.
December 1990, Archiv der Pharmazie,
P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Heterocyclic substituted ureas. 3. Immunosuppressive and antiviral 2-pyrimidylureas.
November 1969, Journal of medicinal chemistry,
P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Synthesis and antimycobacterial activity of some new 3-heterocyclic substituted chromones.
April 1997, Farmaco (Societa chimica italiana : 1989),
P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Synthesis and antiviral activity of diverse heterocyclic scaffolds.
December 2022, Chemical biology & drug design,
P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Synthesis and antiviral activity of substituted quercetins.
January 2012, Bioorganic & medicinal chemistry letters,
P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Design, synthesis, and antiviral activity of certain 3-substituted 2,5,6-trichloroindole nucleosides.
November 2004, Journal of medicinal chemistry,
P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Substituted adamantylphthalimides: Synthesis, antiviral and antiproliferative activity.
June 2020, Archiv der Pharmazie,
P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Heterocyclic substituted ureas. II. Immunosuppressive and antiviral activity of benzothiazole- and benzoxazoleureas.
November 1969, Journal of medicinal chemistry,
P Wigerinck, and A Van Aerschot, and G Janssen, and P Claes, and J Balzarini, and E De Clercq, and P Herdewijn
Synthesis, antimicrobial and antiviral activity of substituted benzimidazoles.
October 2009, Journal of enzyme inhibition and medicinal chemistry,
Copied contents to your clipboard!